Coherus Oncology
CHRS
CHRS
109 hedge funds and large institutions have $1.05B invested in Coherus Oncology in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 49 increasing their positions, 40 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
5% less funds holding
Funds holding: 115 → 109 (-6)
14% less call options, than puts
Call options by funds: $4.83M | Put options by funds: $5.65M
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
Holders
109
Holding in Top 10
2
Calls
$4.83M
Puts
$5.65M
Top Buyers
| 1 | +$20.3M | |
| 2 | +$10.1M | |
| 3 | +$7.98M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.71M |
| 5 |
PC
Pier Capital
Stamford,
Connecticut
|
+$6.34M |
Top Sellers
| 1 | -$10.2M | |
| 2 | -$7.29M | |
| 3 | -$7.15M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$4.93M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$4.36M |